跳至主要内容
临床试验/NCT07654036
NCT07654036已完成不适用

Preliminary Evaluation of a Large Language Model-Based Tool for Complex Surgical Decision Support in Lung Cancer

Peking University People's Hospital1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2026年6月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
8
试验地点
1

研究概览

简要总结

This study is an exploratory effect-size estimation study, with the following specific objectives: ① to estimate the point estimate and 95% confidence interval of the Win Ratio for the experimental group (GAPS-Agent) versus the control group (large language model) in blinded pairwise preference judgments by thoracic surgery expert adjudicators, to serve as a sample size planning parameter for subsequent multicenter confirmatory clinical trials; ② to preliminarily evaluate the value of GAPS-Agent within clinical workflows.The hypothesis of this study is as follows: compared with a general-purpose large language model without medical enhancement (control group), a structured agentic workflow optimized on the basis of the GAPS evaluation framework (GAPS-Agent, experimental group) can help junior resident physicians generate clinical decision plans for complex lung cancer cases that are more strongly preferred by senior thoracic surgery expert adjudicators.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Resident Physician Subjects:
  • Holds a valid and legally effective Physician Practice License of the People's Republic of China;
  • Currently holds the rank of resident physician in a thoracic surgery department at a tertiary Class A (3A) hospital;
  • Agrees to complete all assessment tasks of the main study phase in accordance with the study protocol;
  • Can guarantee the time and effort required to complete all assessment tasks of the main study.
  • Study Cases:
  • The case was discussed at the Thoracic Oncology Multidisciplinary Team (MDT) conference of Peking University People's Hospital between January 2025 and May 2026;
  • The current version of the NCCN guidelines does not provide an explicit recommendation covering the management of the case;
  • Does not overlap with the GAPS evaluation set;
  • The case is presented in pure text in a structured format, with all direct and indirect identifiers removed and complete de-identification performed prior to inclusion;
  • From the pool of eligible cases, 12 cases will be randomly drawn using Python (numpy.random, with a fixed and archived seed) to serve as the main study cases. The cases will cover 6 themes (chest mass of undetermined diagnosis, early-stage lung cancer, locally advanced lung cancer, oligometastatic/oligoprogressive disease, special intraoperative situations, and tumor recurrence), with 1 - 4 cases per theme.
  • Adjudication Expert Panel:
  • Holds a valid and legally effective Physician Practice License of the People's Republic of China;
  • Currently holds the rank of attending physician or above in a thoracic surgery department at a tertiary Class A hospital;
  • Chairs or regularly participates in lung cancer multidisciplinary team (MDT) work in their department.

排除标准

  • Resident Physician Subjects:
  • Has previously participated in the construction of the GAPS evaluation set or the development of GAPS-Agent;
  • Unable to complete the tasks of the study phase.
  • Study Cases:
  • Key case information is missing, such as text-form data on pathology (including IHC/NGS), imaging, laboratory tests, prior medical history, comorbidities, or PS score;
  • Decision-making for the case is strictly dependent on non-text information.
  • Adjudication Expert Panel:
  • Participated in the construction of the GAPS evaluation set, the content validity verification, or the development of GAPS-Agent for this study;
  • Has a direct conflict of interest with any specific product among the two-arm tools of this study.

研究组 & 干预措施

control arm

Active Comparator

LLM

干预措施: LLM (Other)

test arm

Experimental

GAPS-Agent

干预措施: GAPS-Agent (Other)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

XiuYuan Chen

Associate Chief Physician

Peking University People's Hospital

研究点 (1)

Loading locations...

相似试验